After a productive period of Chairmanship since 2022, Neuro-Bio is pleased to share that Dr Michal Zurawski will be transitioning to the role of Chairman of the Commercial Advisory Board. We would like to thank Mike for his contribution during his time as Chairman and look forward to his impact in his new role.
LATEST NEWS
- Baroness Greenfield to attend NeuRA (Neuroscience Research Australia) Sydney in May 2024!
- Baroness Greenfield to speak at the Early Career Dementia Researchers Retreat in June 2024!
- Transforming Alzheimer’s Disease Detection – Collaboration with Aptamer Group
- THENA Capital podcast with Baroness Susan Greenfield
- Neuro-Bio and Aptamer enter the second phase of Alzheimer’s test development